Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Adenuric · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 (see also section 4
Eintrag öffnenAdrovance · 4.3 · - Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAdtralza · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAdtralza · 4.5 · For information on live and live attenuated vaccines, see section 4.4.
Eintrag öffnenAdvagraf · 4.3 · Hypersensitivity to tacrolimus, or to any of the excipients listed in section 6.1. Hypersensitivity to other m
Eintrag öffnenAdvate · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAdvate · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAdynovi · 4.8 · The use of ADYNOVI in children below 12 years is not indicated (see section 4.2 for information on paediatric
Eintrag öffnenAdynovi · 4.8 · The use of ADYNOVI in children below 12 years is not indicated (see section 4.2 for information on paediatric
Eintrag öffnenAerinaze · 4.3 · Hypersensitivity to the active substances, to any of the excipients listed in section 6.1, or to adrenergic me
Eintrag öffnenAerinaze · 4.5 · Aerinaze The following combinations are not recommended: • digitalis (see section 4.4) • bromocriptine • caber
Eintrag öffnenAerius · 4.3 · Hypersensitivity to the active substance, to any of the excipients listed in section 6.1, or to loratadine.
Eintrag öffnenAerius · 4.3 · Hypersensitivity to the active substance, to any of the excipients listed in section 6.1, or to loratadine.
Eintrag öffnenAfinitor · 4.5 · 10 Afinitor (see section 4.4). Examples of live vaccines are: intranasal influenza, measles, mumps, rubella, o
Eintrag öffnenAfinitor · 4.5 · Potentiation of radiation treatment toxicity has been reported in patients receiving everolimus (see sections
Eintrag öffnenAfqlir · 4.3 · Hypersensitivity to the active substance aflibercept or to any of the excipients listed in section 6.1. Active
Eintrag öffnenAfqlir · 4.3 · Hypersensitivity to the active substance aflibercept or to any of the excipients listed in section 6.1. Active
Eintrag öffnenAfstyla · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAhzantive · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Active or susp
Eintrag öffnenAhzantive · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Active or susp
Eintrag öffnen